Medicine
Buspirone 30 mg tablet
Buspirone 30 mg tablet is a generic prescription medicine for oral use, made by 25 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 0 to 25 0 C (68 0 to 77 0 F).
Key facts
- Active ingredient (INN)
- Buspirone
- Brand
- Sold under the generic name
- Strength
- 30 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets, 100 tablets, 500 tablets and 107 more
- Manufacturers
- Zydus LifesciencesIndiaUnichem LaboratoriesIndiaAurobindo PharmaIndiaAvet PharmaceuticalsIndiaStrides PharmaIndiaAccord HealthcareIndiaEpic PharmaOxford PharmaceuticalsAdvagen PharmaAiPing Pharmaceutical25 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20 0 to 25 0 C (68 0 to 77 0 F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05BE01 Buspirone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 August 2001
- Identifiers
- RxCUI 866018, 866083, 866090 +2DailyMed set ID 97f2d082-0931-4e4f-a5be-7792e399e42b, 48b4e52d-d4c4-4d24-a0ac-24316371cef0, 05c006d2-44b9-431f-bce2-aff09c043ecb +34NDC 76420-725, 50090-7652, 59651-393 +36Application ANDA210907, ANDA078246, ANDA078302 +11
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 25 labelers. The register lists 110 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet in 1 bottle | 42543-744-03 | Strides PharmaIndia | 1 April 2021 |
| 60 tablet in 1 bottle | 64380-744-03 | Strides PharmaIndia | 30 June 2015 |
| 100 tablet in 1 bottle, plastic | 29300-247-01 | Unichem LaboratoriesIndia | 20 November 2019 |
| 500 tablet in 1 bottle, plastic | 29300-247-05 | Unichem LaboratoriesIndia | 20 November 2019 |
| 60 tablet in 1 bottle, plastic | 29300-247-16 | Unichem LaboratoriesIndia | 20 November 2019 |
| 100 tablet in 1 bottle, plastic | 29300-478-01 | Unichem LaboratoriesIndia | 22 December 2023 |
| 500 tablet in 1 bottle, plastic | 29300-478-05 | Unichem LaboratoriesIndia | 22 December 2023 |
| 60 tablet in 1 bottle, plastic | 29300-478-16 | Unichem LaboratoriesIndia | 22 December 2023 |
| 500 tablet in 1 bottle | 65841-784-05 | Zydus LifesciencesIndia | 3 May 2014 |
| 1000 tablet in 1 bottle | 65841-784-10 | Zydus LifesciencesIndia | 3 May 2014 |
| 60 tablet in 1 bottle | 65841-784-14 | Zydus LifesciencesIndia | 3 May 2014 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 65841-784-77 | Zydus LifesciencesIndia | 3 May 2014 |
| 500 tablet in 1 bottle | 68382-183-05 | Zydus LifesciencesIndia | 3 May 2014 |
| 1000 tablet in 1 bottle | 68382-183-10 | Zydus LifesciencesIndia | 3 May 2014 |
| 60 tablet in 1 bottle | 68382-183-14 | Zydus LifesciencesIndia | 3 May 2014 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 68382-183-77 | Zydus LifesciencesIndia | 3 May 2014 |
| 60 tablet in 1 bottle | 16729-289-12 | Accord HealthcareIndia | 15 December 2016 |
| 100 tablet in 1 bottle | 59651-393-01 | Aurobindo PharmaIndia | 21 February 2020 |
| 500 tablet in 1 bottle | 59651-393-05 | Aurobindo PharmaIndia | 21 February 2020 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 59651-393-10 | Aurobindo PharmaIndia | 21 February 2020 |
| 30 tablet in 1 bottle | 59651-393-30 | Aurobindo PharmaIndia | 21 February 2020 |
| 60 tablet in 1 bottle | 59651-393-60 | Aurobindo PharmaIndia | 21 February 2020 |
| 100 tablet in 1 bottle | 23155-097-01 | Avet PharmaceuticalsIndia | 20 September 2018 |
| 500 tablet in 1 bottle | 23155-097-05 | Avet PharmaceuticalsIndia | 20 September 2018 |
| 60 tablet in 1 bottle | 23155-097-06 | Avet PharmaceuticalsIndia | 18 September 2015 |
| 500 tablet in 1 bottle | 42806-086-05 | Epic Pharma | 17 April 2019 |
| 60 tablet in 1 bottle | 42806-086-60 | Epic Pharma | 17 April 2019 |
| 60 tablet in 1 bottle | 42806-665-60 | Epic Pharma | 19 June 2020 |
| 500 tablet in 1 bottle | 72888-066-05 | Advagen Pharma | 16 March 2021 |
| 60 tablet in 1 bottle | 72888-066-60 | Advagen Pharma | 16 March 2021 |
| 500 tablet in 1 bottle | 11788-061-05 | AiPing Pharmaceutical | 26 September 2025 |
| 60 tablet in 1 bottle | 11788-061-60 | AiPing Pharmaceutical | 26 September 2025 |
| 60 tablet in 1 bottle | 24689-933-06 | Apnar Pharma | 17 June 2024 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 51079-994-20 | Mylan Institutional | 1 December 2002 |
| 60 tablet in 1 bottle, plastic | 0378-1175-91 | Mylan Pharmaceuticals | 1 August 2001 |
| 60 tablet in 1 bottle | 69584-094-06 | Oxford Pharmaceuticals | 1 May 2020 |
| 180 tablet in 1 bottle | 69584-094-18 | Oxford Pharmaceuticals | 1 May 2020 |
| 500 tablet in 1 bottle | 69584-094-50 | Oxford Pharmaceuticals | 1 May 2020 |
| 60 tablet in 1 bottle | 77771-238-60 | Radha Pharmaceuticals | 18 September 2025 |
| 60 tablet in 1 bottle | 64980-654-06 | Rising Pharma Holdings | 27 February 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 September 1986 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Buspirone
Clinical summary
Buspirone is a prescription medicine indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. It is available as tablets and capsules for oral use. MedsAcross supplies Buspirone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BuspironeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Buspirone Hydrochloride prescribing information (Accord Healthcare) · U.S. National Library of Medicine, DailyMed
Need Buspirone 30 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.